The future of PI3K/AKT/mTOR inhibitors in breast cancer
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Next generation sequencing in oncology
Opportunities and complications of PET CT
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence
The role of physicians and researchers in the medical community
Next generation gene sequencing
Closing the cancer divide: Implementing the diagonal approach
Myeloma UK
Myeloma in Asia
Validation of genomic grade index histological grading in invasive breast cancer